There is no single official list of exactly 38 drugs that cause drug-induced lupus. The number “38” circulates online, but the actual count of medications linked to drug-induced lupus erythematosus (DIL) has grown well beyond that as newer drugs, particularly biologics and cancer immunotherapies, have entered the picture. More than 100 medications have now been associated with DIL to varying degrees. What most people searching for this list really need is a clear breakdown of which drugs carry the highest risk, which carry moderate risk, and what to watch for.
High-Risk Medications
Only a handful of drugs carry a well-documented, high probability of triggering drug-induced lupus. Procainamide, a heart rhythm medication, has the highest incidence at roughly 20% per year of use. Hydralazine, a blood pressure drug, follows at 5% to 8% per year of treatment. Both of these medications are prescribed far less frequently today than they were decades ago, which is one reason drug-induced lupus from these classic culprits has become rarer.
Isoniazid, used to treat and prevent tuberculosis, is also considered a high-risk medication. These three drugs account for the majority of well-studied DIL cases in the medical literature and are the ones most commonly cited in textbook lists.
Moderate-Risk and Commonly Cited Drugs
A larger group of medications has been associated with DIL at lower but still notable rates. These are the drugs that fill out most versions of the “list” people search for:
- Heart and blood pressure drugs: quinidine, methyldopa, captopril, acebutolol, hydrochlorothiazide
- Anti-seizure drugs: carbamazepine, phenytoin, valproic acid, ethosuximide
- Antibiotics and antimicrobials: minocycline, nitrofurantoin, sulfonamides
- Thyroid medication: propylthiouracil
- Psychiatric medications: chlorpromazine, lithium
- Anti-inflammatory and immune-related drugs: sulfasalazine, penicillamine, gold salts
- Cholesterol drugs: statins (lovastatin, simvastatin, and others in rare cases)
- Other: interferon-alfa, terbinafine, griseofulvin
Minocycline deserves special mention. It is one of the most common causes of DIL seen today, particularly in younger patients taking it long-term for acne. Unlike classic DIL, minocycline-induced lupus sometimes causes liver inflammation and positive tests for a different type of autoantibody than the one typically seen in DIL.
Newer Biologics and Immunotherapies
The list of drugs linked to DIL has expanded significantly in recent years. TNF-alpha inhibitors, a class of biologic drugs used for conditions like rheumatoid arthritis and Crohn’s disease, are now among the most commonly reported causes. These include etanercept, infliximab, and adalimumab. Many patients on these medications develop lupus-related autoantibodies without ever developing symptoms, but a smaller percentage go on to experience full DIL.
Cancer immunotherapy drugs such as pembrolizumab, which work by activating the immune system to fight tumors, can also trigger drug-induced lupus as part of a broader range of autoimmune side effects. As these medications become more widely used, DIL cases linked to them are increasingly reported.
How Drug-Induced Lupus Differs From Regular Lupus
Drug-induced lupus shares many surface-level features with systemic lupus erythematosus (SLE), the “regular” autoimmune form. Joint pain, muscle aches, fatigue, and fever are common in both. Skin rashes can occur in either condition. But there are important differences that generally make DIL a milder disease.
DIL rarely affects the kidneys or brain, which are two of the most serious complications of SLE. Blood abnormalities like low white blood cell counts, anemia, and low platelet counts, all common in SLE, are much less frequent in drug-induced lupus. Complement levels, a set of immune proteins that drop in active SLE, typically remain normal in DIL.
The most useful lab distinction is the antihistone antibody test. These antibodies are positive in more than 75% of people with drug-induced lupus but only about 20% of people with SLE. A positive antihistone antibody test in someone taking a known trigger medication is a strong signal pointing toward DIL rather than SLE. However, a negative result doesn’t rule it out entirely.
Who Is at Higher Risk
Not everyone taking a high-risk medication develops drug-induced lupus. Genetic factors play a significant role. People who are “slow acetylators,” meaning their liver processes certain drugs more slowly due to inherited enzyme variations, are at higher risk when taking medications like hydralazine, procainamide, or isoniazid. This trait is more common in some populations than others and explains why two patients on the same drug at the same dose can have very different outcomes.
Duration of use matters too. DIL typically develops after months to years of continuous treatment, not after a few doses. The longer someone takes a trigger medication, the higher the cumulative risk.
Symptoms to Recognize
The most common symptoms of drug-induced lupus are joint pain and swelling, muscle aches, fatigue, and low-grade fever. Some people develop a skin rash, and chest pain from inflammation around the lungs or heart (pleurisy or pericarditis) occurs in a notable number of cases. These symptoms tend to come on gradually and can easily be mistaken for the condition the medication was originally prescribed to treat, which sometimes delays the correct diagnosis.
If you are taking any medication on the lists above and develop new joint pain, unexplained fevers, or a rash that wasn’t there before, that pattern is worth bringing to your doctor’s attention, especially if the symptoms started weeks to months after beginning the drug.
What Happens After the Drug Is Stopped
The defining feature of drug-induced lupus, and the best news about it, is that it resolves after the triggering medication is discontinued. Most people see their symptoms improve within days to weeks of stopping the drug. Lab abnormalities, particularly the autoantibodies, can take longer to normalize, sometimes several months, but they do eventually clear in most cases.
Some people with more significant symptoms may need short-term treatment with anti-inflammatory medications or corticosteroids to manage the flare while it subsides. In rare cases, symptoms can linger for months, but progression to permanent SLE is uncommon. The key is identifying the drug connection early so the medication can be stopped and replaced with an alternative.